Exosomes
are
essential
indicators
of
molecular
mechanisms
involved
in
interacting
with
cancer
cells
and
the
tumor
environment.
As
nanostructures
based
on
lipids
nucleic
acids,
exosomes
provide
a
communication
pathway
for
information
transfer
by
transporting
biomolecules
from
target
cell
to
other
cells.
Importantly,
these
extracellular
vesicles
released
into
bloodstream
most
invasive
cells,
i.
e.,
cells;
this
way,
they
could
be
considered
promising
specific
biomarker
diagnosis.
In
matter,
CRISPR-Cas
systems
microfluidic
approaches
practical
tools
diagnosis
understanding
biology.
systems,
as
genome
editing
approach,
way
inactivate
or
even
remove
gene
without
affecting
intracellular
mechanisms.
These
vital
about
factors
development
that
lead
more
effective
treatment.
Meanwhile,
can
also
significantly
benefit
research
due
their
proper
sensitivity,
high
throughput,
low
material
consumption,
cost,
advanced
spatial
temporal
control.
Thereby,
employing
CRISPR-Cas-
microfluidics-based
toward
exosome
monitoring
valuable
source
therapy
This
review
assesses
recent
progress
accurate
in-depth
study
behavior.
Cells,
Год журнала:
2023,
Номер
12(13), С. 1763 - 1763
Опубликована: Июль 1, 2023
Amyotrophic
lateral
sclerosis
(ALS)
is
a
severe
and
incurable
neurodegenerative
disease
characterized
by
the
progressive
death
of
motor
neurons,
leading
to
paralysis
death.
It
rare
high
patient-to-patient
heterogeneity,
which
makes
its
study
arduous
complex.
Extracellular
vesicles
(EVs)
have
emerged
as
important
players
in
development
ALS.
Thus,
ALS
phenotype-expressing
cells
can
spread
their
abnormal
bioactive
cargo
through
secretion
EVs,
even
distant
tissues.
Importantly,
owing
nature
composition,
EVs’
formation
be
exploited
for
better
comprehension
this
elusive
identification
novel
biomarkers,
well
potential
therapeutic
applications,
such
those
based
on
stem
cell-derived
exosomes.
This
review
highlights
recent
advances
role
EVs
etiopathology
how
promising
new
strategies.
Pharmaceutics,
Год журнала:
2023,
Номер
15(7), С. 1903 - 1903
Опубликована: Июль 7, 2023
Bioinspired
(or
biologically
inspired)
drug
delivery
systems
(DDSs)
have
been
intensively
studied
in
the
last
decades.
As
bioinspired
DDSs,
membrane
vesicles,
including
extracellular
vesicles
(EVs)
released
from
eukaryotic
cells,
outer
(OMVs)
bacteria,
cell-bound
(CBMVs)
isolated
situ
cell
surfaces,
reorganized
after
isolation
of
plasma
and
others
rapidly
developed
are
attracting
more
attention.
Most
recently,
a
collection
25
papers
on
advances
vesicle-based
was
published
Special
Issue
Pharmaceutics
entitled
“Advances
systems”.
These
cover
many
related
topics
source,
preparation,
modification,
loading,
vivo
administration
biodistribution
(mainly
or
exosomes
bacterial
vesicles),
as
well
application
DDSs
treatment
various
diseases.
With
the
severity
of
chronic
kidney
disease
worldwide,
strategies
to
recover
renal
function
via
tissue
regeneration
provide
alternatives
replacement
therapy.
To
exclude
side
effects
from
direct
cell
transplantation,
extracellular
vesicles
(EVs)
are
great
substitutes
representing
paracrine
signaling.
build
three-dimensional
structures
for
implantation
into
5/6
nephrectomy
model
by
incorporating
bioactive
materials,
including
multifunctional
EVs
(mEVs),
porous
PMEZE/mEV
scaffolds
were
developed
in
combination
with
edaravone
(EDV;
E)
and
mEV
based
on
PMEZ
PLGA
(P),
MH-RA
(M),
ECM
(E),
ZnO-ALA
(Z).
The
oxygen
free
radical
scavenger
EDV
was
incorporated
induce
tubular
regeneration.
mEVs
engineered
serve
regenerative
activities
a
two
SDF-1α
overexpressed
tonsil-derived
mesenchymal
stem
cells
(sEVs)
intermediate
mesoderm
(IM)
during
differentiation
progenitor
(dEVs).
displayed
beneficial
facilitating
migration
inducing
surrounding
cells,
improved
regulating
GDNF/RET
pathway
their
downstream
genes.
promotion
MSC
recruitment
confirmed
sEV
particles
number
dependently,
regulation
effect
its
enhanced
elucidated
using
vitro
analysis.
tubules
additionally
demonstrated
through
increased
expression
aquaporin-1
(AQP-1)
cadherin-16
(CDH16)
proximal
tubules,
calbindin
PAX2
distal
defect
model.
these,
structural
functional
recovery
achieved
mice
Exosomes
are
essential
indicators
of
molecular
mechanisms
involved
in
interacting
with
cancer
cells
and
the
tumor
environment.
As
nanostructures
based
on
lipids
nucleic
acids,
exosomes
provide
a
communication
pathway
for
information
transfer
by
transporting
biomolecules
from
target
cell
to
other
cells.
Importantly,
these
extracellular
vesicles
released
into
bloodstream
most
invasive
cells,
i.
e.,
cells;
this
way,
they
could
be
considered
promising
specific
biomarker
diagnosis.
In
matter,
CRISPR-Cas
systems
microfluidic
approaches
practical
tools
diagnosis
understanding
biology.
systems,
as
genome
editing
approach,
way
inactivate
or
even
remove
gene
without
affecting
intracellular
mechanisms.
These
vital
about
factors
development
that
lead
more
effective
treatment.
Meanwhile,
can
also
significantly
benefit
research
due
their
proper
sensitivity,
high
throughput,
low
material
consumption,
cost,
advanced
spatial
temporal
control.
Thereby,
employing
CRISPR-Cas-
microfluidics-based
toward
exosome
monitoring
valuable
source
therapy
This
review
assesses
recent
progress
accurate
in-depth
study
behavior.